title: Human amnion epithelial cells expressing HLA-G as novel cell-based treatment for liver disease.
abstract: Despite routine liver transplantation and supporting medical therapies, thousands of patients currently wait for an organ and there is an unmet need for more refined and widely available regenerative strategies to treat liver diseases. Cell transplants attempt to maximize the potential for repair and/or regeneration in liver and other organs. Over 40years of laboratory pre-clinical research and 25years of clinical procedures have shown that certain liver diseases can be treated by the infusion of isolated cells (hepatocyte transplant). However, like organ transplants, hepatocyte transplant suffers from a paucity of tissues useful for cell production. Alternative sources have been investigated, yet with limited success. The tumorigenic potential of pluripotent stem cells together with their primitive level of hepatic differentiation, have limited the use of stem cell populations. Stem cell sources from human placenta, and the amnion tissue in particular are receiving renewed interest in the field of regenerative medicine. Unlike pluripotent stem cells, human amnion epithelial (AE) cells are easily available without ethical or religious concerns; they do not express telomerase and are not immortal or tumorigenic when transplanted. In addition, AE cells have been reported to express genes normally expressed in mature liver, when transplanted into the liver. Moreover, because of the possibility of an immune-privileged status related to their expression of HLA-G, it might be possible to transplant human AE cells without immunosuppression of the recipient.
authors.affiliation: Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Strom
authors.affiliation: Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden. Electronic address: roberto.gramignoli@ki.se.
authors.forename: Roberto
authors.initials: R
authors.lastname: Gramignoli
mesh_terms: D053687:Adult Stem Cells / Q000276:immunology / Q000637:transplantation; D000650:Amnion / Q000166:cytology*; D064987:Cell- and Tissue-Based Therapy; D002986:Clinical Trials as Topic; D004847:Epithelial Cells / Q000166:cytology / Q000378:metabolism / Q000637:transplantation*; D005260:Female; D059951:HLA-G Antigens / Q000378:metabolism*; D022781:Hepatocytes / Q000276:immunology / Q000637:transplantation; D006801:Humans; D007108:Immune Tolerance; D008099:Liver / Q000502:physiology*; D008107:Liver Diseases / Q000276:immunology / Q000628:therapy*; D008115:Liver Regeneration; D016031:Liver Transplantation
chemical_list: D059951:HLA-G Antigens
keywords: Amnion epithelial cell; Cell therapy; HLA-G; Liver; Metabolism; Placenta